Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-007971
Filing Date
2025-05-01
Accepted
2025-04-30 21:42:57
Documents
139
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 3797403
2 EX-2.2 ex2-2.htm EX-2.2 21185
3 ex4-4.htm EX-4.4 105597
4 ex4-5.htm EX-4.5 95998
5 ex4-6.htm EX-4.6 86092
6 ex4-7.htm EX-4.7 129496
7 ex4-8.htm EX-4.8 98030
8 ex8-1.htm EX-8.1 9064
9 ex11-1b.htm EX-11.1B 70138
10 ex12-1.htm EX-12.1 13889
11 ex12-2.htm EX-12.2 13987
12 ex13-1.htm EX-13.1 5935
13 ex13-2.htm EX-13.2 5826
14 form20-f_001.jpg GRAPHIC 1679551
15 ex4-5_001.jpg GRAPHIC 6123
  Complete submission text file 0001641172-25-007971.txt   17736770

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE incr-20241231.xsd EX-101.SCH 115563
17 XBRL CALCULATION FILE incr-20241231_cal.xml EX-101.CAL 133372
18 XBRL DEFINITION FILE incr-20241231_def.xml EX-101.DEF 286883
19 XBRL LABEL FILE incr-20241231_lab.xml EX-101.LAB 702406
20 XBRL PRESENTATION FILE incr-20241231_pre.xml EX-101.PRE 538409
141 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 2339453
Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Filer) CIK: 0001857030 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40614 | Film No.: 25899040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)